Arkolith/Insider Trading/RNA/Form 4

Gallagher Kathleen P.

Chief Program OfficerAvidity Biosciences, Inc. (RNA) · full profile →Form 4 · filed Sep 2, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 2, 2025Sell(S)188$47.42$9K50K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599901-25-000171) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML